News
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
2d
Pharmaceutical Technology on MSNVertex wins European approval for Alyftrek, bolstering cystic fibrosis strongholdWith its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
Two brothers and two friends take on and wi, an 80-mile Atlantic paddleboard challenge in an effort to provide support for ...
While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...
Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.
The prevalence of food allergy is significantly lower in children with cystic fibrosis than in those without the condition in ...
North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...
Cystic Fibrosis is a rare autosomal recessive disease that causes sticky mucus to build up in the lungs, affecting numerous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results